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Abstract: The establishment of more efficient approaches for developmental neurotoxicity 
testing (DNT) has been an emerging issue for children’s environmental health. Here we 
describe a systematic approach for DNT using the neuronal differentiation of mouse 
embryonic stem cells (mESCs) as a model of fetal programming. During embryoid body 
(EB) formation, mESCs were exposed to 12 chemicals for 24 h and then global gene 
expression profiling was performed using whole genome microarray analysis. Gene 
expression signatures for seven kinds of gene sets related to neuronal development and 
neuronal diseases were selected for further analysis. At the later stages of neuronal cell 
OPEN ACCESSInt. J. Mol. Sci. 2012, 13 188 
 
differentiation from EBs, neuronal phenotypic parameters were determined using   
a high-content image analyzer. Bayesian network analysis was then performed based on 
global gene expression and neuronal phenotypic data to generate comprehensive networks 
with a linkage between early events and later effects. Furthermore, the probability distribution 
values for the strength of the linkage between parameters in each network was calculated 
and then used in principal component analysis. The characterization of chemicals 
according to their neurotoxic potential reveals that the multi-parametric analysis based on 
phenotype and gene expression profiling during neuronal differentiation of mESCs can 
provide a useful tool to monitor fetal programming and to predict developmentally 
neurotoxic compounds. 
Keywords: developmental neurotoxicity; embryonic stem cells; high-content screening; 
Bayesian network modeling; gene expression; multi-parametric analysis 
 
1. Introduction 
One of the emerging issues in developmental neurotoxicology is to detect effects of chemicals on 
fetal programming, which is defined as variations in metabolism, gene expression and genome 
modification during fetal life that induce or repress the somatic structure and physiological systems after 
development [1–4]. A significant issue in the prevention of neurodevelopmental deficits of chemical 
origin is the paucity of testing of chemicals for developmental neurotoxicity [5]. New, precautionary 
approaches that recognize the unique vulnerability of the developing brain are needed for testing and to 
control the use of chemicals. 
Toxicity testing using embryonic stem cells (ESCs) is an efficient approach for developmental 
neurotoxicity testing (DNT) [6,7]. Compared with the DNT in animal studies, which are costly, 
time-consuming, and require considerable numbers of laboratory animals, the ESCs test is unique in 
that, in a relatively simple cell-line-based assay, it incorporates the entire differentiation route from 
pluripotent ESCs into differentiated cells [8]. Furthermore, as the neuronal differentiation of ESCs 
provides insight into the early neurogenesis during embryonic development, several protocols have 
been developed based on the disturbances of this process to model developmental neurotoxicity [9,10]. 
A 13-day neural differentiation protocol of mouse embryonic stem cells (mESCs), which is combined 
with morphological observation, immunocytochemistry, gene expression and flow cytometry, has been 
applied to assess the developmental neurotoxicity of methyl mercury chloride [9]. More recently, a 
broad gene expression profile during a 20-day differentiation process of mESCs has been successfully 
designed, in which transcription-based end points have been used to identify the disturbed neuronal 
differentiation of mESCs [10]. Developing neurons display plasticity in the type of neurotransmitter 
phenotype that they can assume, and alterations of synaptic activity and expression of neurotrophic 
factors can influence the “wiring” of developing neuronal circuits [11]. Consequently, exposure to 
environmental chemicals that promote or interfere with synaptic activity or expression/function of 
neurotrophins can result in miswiring, leading to neurobehavioral anomalies. However, a sensitive Int. J. Mol. Sci. 2012, 13 189 
 
method for quantitatively measuring alterations of fetal programming during neuronal differentiation, 
particularly in the connection between the early disturbances and the later outcomes, has not yet  
been devised. 
Here, we produced a high-content and sensitive method for quantitatively measuring the 
developmental neuronal toxicity of 12 environmental chemicals (see Table 1) using mESCs test 
combined with DNA microarray analysis, morphological analysis and Bayesian approaches. This 
confers a new predictive insight for chemical screening in a complex cell culture system that mimics 
early mammalian embryonic development. We performed multi-parametric profiling of gene expression 
data sampled at the early stage of mESC differentiation and neuronal phenotype data sampled at a later 
stage of neuronal cell differentiation after embryoid body (EB) formation. Then, these sampled data 
were analyzed by a Bayesian network analysis (BNA). This analysis can be depicted graphically to 
represent the probability structure of the causal complex [12–14]. 
Table 1. Summary of 12 test chemicals. 
Chemical Name  Ellipsis  Intended Use 
Physiological Effect 
and Toxicity 
Mode of 
Action 
Target Protein 
Triiodotyronine T3 
Endogenenous 
hormne 
Pseudo thyroid 
hormone  
transcriptional 
regulation 
Thyroid hormone receptor 
(TR)α, TRβ 
Dexamethazone DEX 
Medicinal 
drug 
Pseudo corticosteroid 
hormone 
transcriptional 
regulation 
Glucocorticoid receptor 
(GR) 
17b-Estradiol E2 
Endogenenous 
hormne 
 
transcriptional 
regulation 
Estrogen receptor (ER)α, 
ERβ 
5a-Dihydrotestosterone DHT 
Endogenenous 
hormne 
 
transcriptional 
regulation 
Androgen receptor (AR) 
2,3,7,8-tetrachlorodibenzo-p
-dioxin 
TCDD 
Unintentional 
chemical 
Multi-toxicity 
transcriptional 
regulation 
Aryl hydrocarbon 
receptor (AhR) 
Methoprene acid  MPA  Pesticides  Teretogenecity 
transcriptional 
regulation 
Retinoid X receptor (RXR)α, 
RXRβ, RXRγ 
Cyclopamine CPM 
Medicinal 
drug 
Teretogenecity 
Signal 
inhibition 
Hadgehog signaling 
pathway 
Thalidmide TMD 
Medicinal 
drug 
Teretogenecity and 
Autism 
Unknown Oxidative  stress 
4(OH)-2′,3,3′,4′,5′- 
pentachlorobephenyl 107 
PCB 
Metabolite of 
PBC 
Multi-toxicity Unknown 
Unknown  
(ERα, oxidativestress) 
Permethrin PMT  Pesticides  Neuro-toxicity  Unknown  Oxidative  stress 
Bisphenol A  BPA 
Plastic 
materials 
Reproductive and 
Neuro-toxicity? 
Unknown Unknown  (ERα, ERRγ) 
Bis(2-ethylhexyl) 
phthalate 
DEHP 
Plastic 
materials 
Reproductive and 
Neuro-toxicity? 
Unknown 
Unknown [Peroxisome 
proliferator-activated 
receptor (PPAR)α, 
antiTR] Int. J. Mol. Sci. 2012, 13 190 
 
The Bayesian algorithm used in this study was proposed by Toyoshiba et al. as a prediction tool  
for the effect of exposure to chemicals [15]. The TAO-Gen algorithm is based on the assumption of  
a linear relationship between changes in the expression levels of two genes following chemical 
exposure [16], which employs the Gibbs sampling method on the search algorithm to estimate 
posterior probability distribution [17,18]. The advantage of Gibbs sampling is that it samples from a 
full conditional distribution and it is an efficient and easy sampling procedure. Gibbs sampling is a 
Markov chain Monte Carlo method, which involves generating a sample from one or several variables 
with an acceptance probability of one. This process is repeated until the sampled probability distribution 
is close to the actual distribution. This algorithm can be used to search for key transcription factors of 
signal transduction during ES cell differentiate process [19]. 
Figure 1. Experimental steps in this study for the assessment of developmental neurotoxicity. 
 
Therefore, the overall aim of this paper is to make a conceptual and methodological proposal  
to establish a more efficient approach for DNT (Figure 1). More specifically, two objectives are 
addressed. The first is to describe the DNT design and to identify multi-parametric profiling networks 
(MPNs) multiple-index networks for 12 environmental chemicals as examples. These are based on the Int. J. Mol. Sci. 2012, 13 191 
 
gene expression signatures of mESCs and phenotype profiling of neurons differentiated from EBs. The 
second objective is to suggest an information-predictive approach to detect alterations of fetal 
programming that can be made operational using BNA. We propose BNA as an operational tool for 
empirically applying the DNT approach. 
2. Results and Discussion 
2.1. Phenotype Profiling Based on the Morphology of Differentiated Neuronal Cells by High-Content 
Image Analysis and Generation of Phenotypic Networks 
EBs neurally differentiated into neural cells after transfer to OP/L-coated plates. Effects of the  
12 environmental chemicals on neural cell growth and NS morphology are shown in Figure 2. 
Dexamethazone (Dex), Permethrin (PMT) and 17β-estradiol (E2) significantly increased neurite length, 
while 4-OH-2′,3,3′,4′,5′-pentachlorobephenyl 107 (PCB), triiodotyronine (T3), Thalidmide (TMD), 
cyclopamine (CPM) and methoprene acid (MPA) significantly decreased neurite length compared  
with DMSO control (Figure 2A). In glial fibrillary acidic protein (GFAP) positive glial cells, Dex, 
5α-dihydrotestosterone (DHT), bisphenol A (BPA) and PCB significantly increased neurite length, 
while TMD significantly decreased neurite length (Figure 2B). Chemicals were then classified based on 
morphological features by MPN analysis to extract and predict their toxicities. 12 phenotypic networks 
(PNs) were generated from the MPN analysis based on the phenotypes of neuronal cells and NSs. We 
manually classified three categories out of the12 PNs depending on network structures (Figure 3). 
Figure 2. Morphological data of MAP2-positive neurons and glial cells. (A) Total length 
of MAP2-positive neurons per well; (B) Total length of glial processes per well. * P < 0.05, 
** P < 0.001 vs. the vehicle control (DMSO). 
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Figure 2. Cont. 
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Figure 3. Classification based on morphological imaging and phenotypic feature networks. 
Class 1: Extension from the turning point is short while the neurite is long; Class 2: Neurite 
is long and the branch point is complex; Class 3: Neurite is short and there are many 
nucleus count. 
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2.2. Generation of a Comprehensive Network Based on Gene Expression and Phenotype Profiling by  
a Bayesian Network Model 
A significant advantage of our unique MPN analysis is that it can predict the correlation coefficient 
for each pair of nodes, regardless of the data types. Our initial efforts were to derive the interactions 
between variations of gene expression data after chemical exposure at the early stage of mESC 
differentiation and effects on the neuronal phenotype data sampled at a later stage of neuronal cell 
differentiation after EB formation. That is to perform a comprehensive analysis combining data from 
two different properties. We extracted a discriminative gene group as a gene expression signature from 
exhaustive genetic profiling, each group was defined by their characteristic category (Table 2) and these 
gene sets were used in a gene and phenotype interaction network (GPIN) with cell morphological data 
(Figure 4). To verify whether the MPN analysis can draw out the developmental neurotoxicity, typical 
examples of DPINs for autism and Parkinson’s disease related gene sets exposed to TMD and PMT, 
respectively, were discussed. 
Table 2. Lists of 7 gene sets selected for network analysis. 
Alzheimer Autism Parkinson Axon  Guidance Pluripotent Neural  Development Oxidative-Stress
AR AR  AR  1500003O03Rik  Arid3b  Atbf1  Aass 
ApoE Cntnap2  Casp3 Abl1  Esrrb  Cdyl  Als2 
App En2  Casp7  Ablim1  Fkbp3  Fos  Apoe 
Bace Esr1  Casp9  Cfl1  Hdac2 Gbx2  Ctsb 
Casp3 Esr2  Esr1  Cxcl12  Klf4  Gfap  Dnm2 
Casp7 Fmr1  Esr2  Efna4  Mybbp1a  Hras1  Fancc 
Esr1 Foxp2  Park2  Epha2  Nacc1 Map2  Gpx7 
Esr2 Gabrb3  Park7  Ephb1  Nanog  Mapk1  Gpx8 
Ide Mecp2  RARa  Nfatc2  Nfkbib  Mapk3  Gusb 
Il1r1 Nlgn3  RARb  Nfatc3  Nr0b1 Nestin  Hprt1 
Mme RARa  RARg Ntng1  Nr5a2  Pla2g6  Kif9 
Psen RARb  Slc6a3  Sema3a  Pou5f1  Raf1  Noxo1 
RARa RARg  Snca  Sema3b  Rex1  Rhog  Nxn 
RARb Reln  Th  Sema3d  Sall4  Rif1  Park7 
RARg Slc6a4  Uchl1  Sema3f  Smarcad1  Rps6ka1  Ppp1r15b 
Tnfrsf1a Tsc1    Sema3g  Smarcc1  Sall1  Prdx2 
 Tsc2    Sema6a  Sox2  Shc1  Prdx6-rs1 
 Ube3a    Sema6b  Sp1  Smarcad1 Psmb5 
     Sema6d  Spag1  Sox2  Recql4 
     Srgap3  Trim28  Tuj1  Scd1 
     Unc5d  Zfp281  Map2k1  Slc41a3 
       c-Myc   Sod1 
           Sod3 
           Txnip 
           Txnrd1 
           Xpa Int. J. Mol. Sci. 2012, 13 194 
 
Figure 4. Typical example of GPINs for autism and Parkinson’s disease gene sets. Gene 
expression and morphological parameters were connected by the strength of the correlation. 
GPINs of autism related genes and morphological parameters: (A) the vehicle control 
(DMSO) and (B) TMD exposure. GPINs of Parkinson’s disease related genes and 
morphological parameters; (C) the vehicle control (DMSO) and (D) PMT exposure. 
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In DMSO control GPIN, RARα positively regulates Fmr1 expression via positive regulation of RARγ 
expression, suggesting that RA induced neural differentiation could maintain Fmr1 expression. On the 
other hand, Mecp2, the responsible gene of Rett syndrome, negatively related with Fmr1 expression. It is 
reasonable because Mecp2 plays a role in the transcriptional repression of methylated genes including 
Fmr1 [20]. However, in TMD-exposed GPIN, Fmr1 was not regulated by RARs, indicating the neural 
induction by RA was counteracted by TMD. TMD repressed expression of Fmr1 and Mecp2 and MPN 
analysis also revealed that Fmr1 positively related with Mecp2 in TMD treated EB derivatives. The 
results mean that TMD repressed expression of Mecp2 via repression of Fmr1 expression. It seemed to 
contradict the epigenetic silencing of Fmr1 gene by Mecp2. However, Zhang et al. reported that Mecp2 
mRNA expression level was drastically decreased in the brains of Fmr1 knockout mice, an animal model 
of fragile X syndrome of autism spectrum [21]. This means the relationship between Fmr1 and Mecp2 is 
different between normal and pathological neurons. Additionally, Gabrb3, a subunit of GABA A 
receptor, was positively affected by Mecp2. In Mecp2 deficient mice, subtle dysfunction of GABAergic 
neurons contributes to numerous neuropsychiatric phenotypes [22]. The relationship of morphological 
parameters and gene expression parameters was also changed by TMD. RARs became a hub connecting 
the genes and morphological parameters and NS_formfactor related to expression of some genes 
independently from other morphological parameters in DMSO control GPIN. This result suggests that RA 
induced neural differentiation via RARs, thereby, inducing morphological changes. In TMD-exposed 
GPIN, the morphological parameters were independent from RARs and the expression of Tsc2 related to 
them via positive connection with NS_formfactor. These results also indicated a counteraction by TMD 
against the neural induction by RA. Tcs2 is well known to affect cell proliferation and to control cell size 
and neural development [23]. Therefore, Tsc2 had a high correlativity to morphological parameters. 
Parkinson’s disease is the result of degeneration of dopaminergic neuron expressing Th. Recently, 
some research showed that exposure to pyrethroids including PMT could change the dopaminergic 
system [24,25]. The genes including in the Parkinson set can be divided into three groups, the ubiquitin 
pathway (Park2, Snca and Uchl1) and the mitochondrial pathway (Park7, Casp3, Casp7 and Casp9) [26] 
and genes needed for normal dopaminergic activity (Slc6a3 and Th). In DMSO control GPIN, the 
ubiquitin pathway genes were not connected into the network. The mitochondrial pathway genes were 
connected positively but no connection was detected affecting the expression of Th. These results mean 
that the differentiation of Th positive neuron was not affected by both pathways in normal neuronal 
differentiation. However, in PMT-exposed GPIN, all genes were connected into the network.   
Th expression was positively related by Park7, RAR, Slc6a3 and Uchl1 and negatively related by Snca, 
Esr1, Crossing_point and NS_formfactor. These results suggest the differentiation of Th positive neuron 
was affected in a complex manner in PMT exposed EB derivatives. Interestingly, Park7, Casp3, Snca, 
Park2 and Casp9 were connected indicating the ubiquitin pathway and the mitochondrial pathway 
affected each other as well as they do in dopaminergic neurons of Parkinson’s disease. Th positive 
neuron might die by apoptosis because we detected the increased expression of Casp3 and Casp9 in 
addition to these results. Although all morphological parameters were connected to GPIN in DMSO 
control, the NS morphological parameters (NS_area, NS_count and NS _perimeter) were not connected Int. J. Mol. Sci. 2012, 13 196 
 
to other morphological parameters or genes in the PMT-exposed GPIN. The neurite morphological 
parameters (Neurite_length, Branch_point, Crossing_point and Posi_area) influenced expression of 
genes in contrast to the NS morphological parameters. Considering the significant increase of total 
length of Map2-positive neuron (Figure 2A) and no change in the NS morphological parameters by PMT, 
the PMT-exposed GPIN successfully drew the change of neuronal morphology. 
The comparison of TMD-exposed GPIN or PMT-exposed GPIN with DMSO control GPIN for 
Autism set and Parkinson’s disease set could be understood without contradicting known pathological 
pathways. Therefore, we propose that our MPNs approach could draw out the risk of chemicals. The 
gene expression profiling data of our study have been published on the Profiles of Chemical Effects on 
Cells (pCEC) system [27], which is a toxicogenomics database with a toxicoinformatics system for 
risk evaluation and toxicity prediction of environmental chemicals [28] and produced by the National 
Institute of Environmental Studies, Japan. The microarray data have also been released on the GEO  
data base [29]. 
2.3. Classification of Chemicals Based on the Values of the Parameters of the Comprehensive Networks 
The genomic data and cell morphological data were converted to the same matrix vector and were 
used to analyze GPIN. Principal component analysis (PCA) based on the probabilistic relationship data 
of the GPIN showed that all variance between the 12 chemicals could be described using the first and 
second principal components (PCs) (Figure 5). The two dimensional PCA plot showed four different 
groups: DMSO control (black), TMD group (CPM and DHT, green), BPA group 
[2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), PCB, T3, bis(2-ethylhexyl) phthalate (DEHP) and E2, blue] 
and MPA group (PMT and DEX, red) were derived for the Alzheimer’s disease related gene set. The 
same color coding was used for other experiments, which enabled us to visually recognize changes to the 
grouping of chemicals. When the largest variable variation was placed in the vertical axis (PC1) and 
the second variation in the horizontal axis (PC2), the two-dimensional plot showed the position of each 
chemical. PMT and DEX were located near, but separated from, DMSO in Alzheimer set and Parkinson 
set. The toxic effects of DEX were reported in animal model of Alzheimer’ disease [30] and Parkinson’ 
disease [31] although we found no report about PMT in Alzheimer’s disease. In Alzheimer set, E2 was 
located further away from DMSO than DHT and the opposite positioning was detected in Parkinson set. 
It might reflect the sexual differences of the diseases as the risk of Alzheimer’s disease is higher in 
females [32] and that of Parkinson’s disease is higher in males [33]. Because the responsible genes of 
gender specific Autism spectrum were involved in the Autism set, such gender dependent differences 
might not be detected in present data. In Autism set, TMD was more separate from DMSO than the 
others. Indeed other than TMD, the chemicals show no evidence of involvement in autism at present. In 
the Axon guidance set, all chemicals were almost equally distant from DMSO. As shown in (Figure 2A), 
all chemicals influenced the total length of Map2-positive neuron at high dose. Therefore, this result is 
reasonable. In the pluripotent set, PMT and PCB were separated from the others indicating that these 
chemicals affected the differentiation from ES cells. In fact, PMT and PCB are also located away from 
DMSO in neural development set. The characterization of chemicals according to their neurotoxic Int. J. Mol. Sci. 2012, 13 197 
 
potential reveals that the method described in this current study—that the MPN analysis based on 
phenotype and gene expression profiling during neuronal differentiation of mESCs—can provide a 
useful tool to monitor fetal programming and to predict developmentally neurotoxic compounds. 
Figure 5. PCA based on Bayesian network parameters. PCA were applied to the Bayesian 
network parameters based on phenotypic and global gene expression profiling to evaluate 
the neurotoxicity of 12 environmental chemicals. Score plots based on (A) Alzheimer’s 
disease related gene set; (B) Autism related gene set; (C) Parkinson’s disease related gene 
set; (D) Axon guidance related gene set; (E) Pluripotent related gene set; (F) Neural 
development related gene set; and (G) Oxidative stress related gene set. 
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2.4. Discussion for Future Work 
ESCs test combined with transcriptomics for the assessment of development toxicity has been well 
studied in recent years [8,34]. However, studies based on the genotype-phenotype profiling are rare. Cell 
phenotypes are complex and difficult to quantify in a high throughput fashion. The lack of 
comprehensive phenotype data can prevent or distort genotype-phenotype profiling. Our study 
described a unique approach to perform multiple phenotype profiling using gene expression data from 
the early stage of mESC differentiation and morphological data of neuronal cell differentiation after EB 
formation. Our method provided numerous advantages: (i) Our method can predict multiple phenotype 
profiles, which could help researchers to reveal different aspects of complex diseases and facilitate 
treatment design; (ii) Our method can provide a quantitative phenotype description of the sample 
characteristics; (iii) Our method can extrapolate the profiling to classes beyond those represented in the 
training data. This is an advantage over traditional classification methods. In contrast, traditional 
regression methods cannot be directly applied to microarray datasets from different platforms and 
cannot predict relationships between early events and late phenomena during the differentiation of ES 
cells into neuronal cells. However, our method can be applied to other types of genomics data such as 
proteomics or metabolomics. The present study focuses on linear gene-phenotype associations, but more 
complex relationships can also be devised depending on the data characteristics. Our multi-parametric 
profiling method for constructing interfering networks of the gene expression data and cellular 
phenotypic data is only one of many possible approaches. As mentioned above, our MPN analysis can 
predict the correlation coefficient for each pair of nodes, regardless of the data types. Therefore, our 
informatics approach and experimental design is also an efficient tool for data integration, mining and 
network analysis for the other model systems. However, another important issue for the future will be 
the validation of a larger set of chemicals at a broad concentration range to identify the specific and 
mechanistically defined markers for differential environmental chemicals. 
ES cell-based assays are a promising platform to assess developmental toxicity, because they are 
capable of recapitulating many of the differentiation states and rely on signaling pathways present in 
development. We used a neuronal differentiation assay of mESC to assess the activity of groups of 
environmental chemicals, most of which have in vivo toxicity data. The results of this study 
demonstrated that a subset of tested chemicals are effective in this assay, and that as a statistical analysis, 
BNA, identified predictive models of detecting fetal programming in the mESC differentiation for a 
subset of the tested chemicals. Chandler et al. demonstrated evaluation of environmental chemicals 
using a mESC adherent cell differentiation and cytotoxicity assay, showing that genes involved in 
reactive oxygen species signaling pathways were strongly associated with decreased ES cell 
differentiation [35]. However, their approaches are linear regression or categorical approaches and are 
not identical with our approaches. Our approach is unique in linking early gene expression events to the 
later cellular phenotype features by BNA, which has become popular among biological scientists [36]. 
Many studies using BNA focus on basic physiological and developmental phenomenon based on cell 
proliferation [37]. In contrast, our study targets effects of early exposure on late-onset phenotypes, in 
accordance with the principles of fetal programming against environmental chemicals. In this regard, Int. J. Mol. Sci. 2012, 13 199 
 
this is the first study to combine gene expression data and morphological data to estimate the 
mechanistic path of the response during the early embryonic period. 
3. Experimental Section 
3.1. Selection of Test Chemicals 
Twelve chemicals, mostly well-characterized medical drugs, pesticides or plastic materials, which 
have been previously tested by traditional in vivo toxicology methods, were used in this study (Table 1). 
T3, DEX, E2, DHT and MPA are the agonists of the nuclear receptors, ThRs, GR, ERs, AR and RXRs 
respectively and regulate expression of target genes of each receptor. TCDD also is the agonist of a 
transcription factor termed AhR [38]. Therefore, these chemicals influence differentiation and 
development many tissues including neural tissues. CPM, a well characterized teratogen, is the 
inhibitor of sonic hedgehog (Shh) signal [39]. It can inhibit the acquisition of ventral identity in 
mESCs-derived neural stem cells [40]. TMD is also well known teratogen of human but not rodents 
although the toxicological mechanism remains to be unclear [41]. Human epidemiological studies 
suggested the involvement of TMD in the appearance of autism [42,43]. The studies using rats showed 
that prenatal exposure to TMD could cause autism-like symptoms in rodents [44]. Prenatal or postnatal 
exposure to PCB showed long term effects on brain development and behavior in rat [45]. PMT, BPA 
and DEHP have also shown neurotoxicity in animal models [46–48]. Recently, the TestSmart DNT II 
meeting to discuss about development of alternative testing methods and models for DNT showed a 
list of the candidate chemicals for positive control in DNT [5]. 4 chemicals of our list, TMD, PCB, 
PMT and DEHP are involved in the list. Therefore, the choice of chemicals in present study can be adequate. 
3.2. Design of Multi-Parametric Profiling Networks Analysis for Detecting Developmental Neuronal 
Toxicity of Chemicals That Effects Fetal Programming 
To evaluate developmental neurotoxicity of these chemicals, we designed a MPN analysis based on 
gene expression and cellular phenotypic data. The process of MPN analysis was composed of 5 steps 
(Figure 1). Step 1 involves the exposure of mESCs to chemicals and then the differentiation of mESCs 
into neuronal cells. Cells were exposed to chemicals for 2 days during Day 0 to Day 2 when initial EBs 
were formed. Gene expression determination using microarray analysis was performed on RNAs that 
were sampled immediately after cells were exposed to chemicals. EBs of Day 8 were transferred to 
poly-DL-ornithine/laminine-coated 24 wells plate and cultured until Day 20 when cells had adequately 
differentiated to neuronal phenotypes. Differentiated neuronal cells were visualized by immunofluorescence 
staining. Cell images were acquired automatically using a 10× objective. Gene expression sets selected 
from microarray data and morphological data of neuronal cells were collected into the same matrix  
(Step 2). Seven gene expression signatures (pluripotent, neural development, axon guidance, autism, 
Parkinson’s disease, Alzheimer’s disease and oxidative stress) of biological events and neuronal disease 
were selected manually and are shown in Table 2. The genes in autism set were chosen based on some 
reviews [49–51]. The gene in pluripotent set were chosen based on Wang et al. [52] and Müller et al. [53] 
The KEGG pathway database was referred to choose genes in other sets. Sex steroid receptors (ESR1, Int. J. Mol. Sci. 2012, 13 200 
 
ESR2 and AR) and retinoic acid receptors (RARα, RARβ and RARγ) were added into the autism set, 
Parkinson set, Alzheimer set to consider the gender depending differences and to consider the effects of 
neuronal induction by RA in vitro, respectively. Once transition matrices were made from gene 
expression and neuronal cell phenotypes, phenotypic networks and MPNs were derived by BNA. 
Namely, nodes in the generated GPIN included each of the genes contained in the gene list or each of the 
morphologic parameters, such as neural cell count or neurite length (Step 3 and 4). We then applied 
PCA to classify the generated MPN for 7 gene-signature sets of each test-chemical. The values of 
linkage probability between two nodes in the MPN were used as the parameters in PCA (Step5). 
3.3. mESC Culture and Maintenance 
mESC (B6G-2) derived from Green mouse FM131, a mouse constantly expressing GFP, were 
cultured on deactivated mouse fibroblast cells (RIKEN, Japan). The proliferated cells were replated on 
0.1% gelatin coated dishes with DMEM (phenol red free, Invitrogen, Carlsbad, CA, USA) containing 
15% FBS (fetal bovine serum, Invitrogen), 100 μM NEAA (Non-essential amino acids, Invitrogen), 
100  μM 2-ME (2-mercaptoethanol, Invitrogen) and 1000 U/mL LIF (Leukemia inhibitory factor, 
ESGRO, Invitrogen). 
3.4. EB Formation from mESC and Chemical Treatment 
The microsphere array used in this study is a frame separated type (chip 300, STEM Biomethod 
Corporation, Kitakyushu, Japan), which is made of acrylic resin and the surface has been coated with 
PDMS resin that is not structured for direct cell adhesion. 1024 wells (diameter 300 μm) were 
arranged on the surface of the microsphere array. EB formation was performed in the three dimension 
culture based on the microsphere array. After removal of mouse fibroblast cells, aggregated ES cells 
were counted and 250 μL cell suspension solution (2 × 10
5 cells) were put on the microsphere array. 
Six hours later, the medium was exchanged for each chemical containing medium and incubation 
continued for 48 h. After that, RNA was isolated for gene expression analysis and culture medium was 
exchanged for EB medium with add 10 nM retinoic acid for the further morphological analysis. EBs 
were cultured for 6 days with EB medium replaced every two days. Eight days after chemical 
exposure, aggregated EBs were replated on Ornithine/Laminine coated 24 wells plate (83 EBs/well). 
Twenty-four hours later, EB medium was exchanged for neural differentiation medium (DMEM/F12 (1:1), 
N2 (×100), and 10 ng/mL bFGF) and EBs were cultured for another 20 days, exchanging the medium 
every 3 days. DMSO was used as the primary solvent for all chemicals, and the DMSO solutions were 
further diluted in cell culture media for treatments. The final concentrations of DMSO in the media did 
not exceed 0.1% (vol/vol). The concentrations of chemicals used in this study were: 1 pM and 100 pM 
for BPA; 1 nM and 10 nM for T3, DEX, E2, DHT, PCB and TCDD; 0.1 μM and 10 μM for CPM, 
PMT and TMD; 1 μM and 100 μM for MPA and DEHP. The neuronal differentiation parallel to 
development in vivo was confirmed by quantitative RT-PCR of stage specific markers, Oct3, Nanog, 
Pax6 and Map2 (data not shown). Int. J. Mol. Sci. 2012, 13 201 
 
3.5. Immunofluorescence 
On Day 20, EBs and differentiated cells were immunostained with Mouse anti-MAP2 antibody 
(1:200 dilution; Sigma-Aldrich, St. Louis, MO, USA), Mouse anti-GFAP monoclonal antibody (1:200 
dilution; Chemicon, GA, USA) and Hoechst 33342 solution (Dojindo, Tokyo, Japan). In brief, cells 
were fixed with 4% PFA in PBS for 15 min and then blocked for 30 min in PBT buffer (PBS with 5% 
Goat serum and 0.1% Triton). Cells with primary antibodies were incubated overnight at 4 °C. Cells 
were washed and blocked in BBT-BSA and then incubated with Alexa-conjugated secondary 
antibodies (1:1000 dilution, Alexa Fluor 546, Invitrogen). Hoechst 33342 staining was used for 
counter staining. 
3.6. Morphological Analysis of mESC, EB and Neuronal Cell Lineages 
The immunofluorescence images were acquired using the IN Cell Analyzer 1000 (GE Healthcare, 
Buckinghamshire, UK). Each neural cell image was analyzed using image analysis software IN Cell 
Developer Tool Box 1.7 (GE Healthcare). The following 10 parameters were measured: number of all 
cells (Nuc_count), nucleus area (Nuc_area), the number, area, perimeter and formation of neurospheres 
(NS), (NS_count, NS_area, NS_perimeter and NS_formfactor), and the shape of nerve cells and the size 
of neural marker positive cells (posi_area, Neurite_length, Branch_point and Crossing_point). 
3.7. Gene Expression Analysis and Creation of Candidate Gene Sets 
Total RNA on Day 2 of cells derived from mESCs were applied to Illumina beads array systems 
with the Illumina Mouse WG-6 v1.0 expression beadchip (Illumina, San Diego, CA, USA). The 
amounts, purity and integrity of RNA were evaluated by UV spectrophotometry and an Agilent 
Bioanalyzer 2100 (Agilent Technologies, Palo Alto, CA, USA). Genes were normalized with 
analytical software GeneSpring GX10.02 (Agilent Technologies) [54]. 7 sets of genes were created 
with reference to the literature to assess the impact on neural development. These categories were 
Pluripotent, Neural development, Axon guidance, Autism, Parkinson’s disease, Alzheimer’s disease, 
and Oxidative stress. 
3.8. Gene and Morphology Interaction Network Analysis 
GPIN was quantified to calculate the posterior probability distribution for the strength of the 
linkages based on gene expression, morphological and chemical exposure dose datasets. Briefly, a GPIN 
consists of a collection of P nodes, denoted G1, G2, … GP, with observed values n1, n2, …. np. Define ij 
(i,j = 1,2, …, P) as parameters in the log-linear function form describing the linkage from node i to 
node j. Mathematically, this is written as: 
 
 
P
j i
i ij ij j g I G E
, 1
) log( )] [log(    (1) 
where E[log(Gj)] represents the expectation for the natural logarithm of Gj and Iij (i,j = 1,2, …, P) is an 
indicator function that equals 1 if node Gi has a link to node Gj, otherwise it equals 0. If a node has a 
regulatory effect on node Gi, then that node is referred to as a “Parent of node Gi” and we refer to it as Int. J. Mol. Sci. 2012, 13 202 
 
belonging to the set Pa(Gi). The prior distribution for the variance is assumed to be inverse Gamma 
and assuming that the natural log of Gj follows a normal distribution with mean and standard 
deviation, posterior distributions for each parameter can be estimated. The posterior distributions for 
the linkages were derived using Gibbs sampling. Gibbs sampling has no limitation on the number of 
possible parents and is easy to cooperate with knowledge information or past experimental results by 
taking the information into the prior distribution. The goal of the method is to examine the posterior 
distribution of the linkages between genes. In this study, we applied 20 sets of gene expression data  
(N = 30) and morphological data (N = 162). Network was used to evaluate the ability of the algorithm 
to have higher posterior probability (P-value) at the correct linkage in GPIN. In each simulation, Gibbs 
sampling was performed between 33,000 and 48,000 times. The initial Gibbs sampling was considered 
to be the burn-in period and was removed in estimating and the last 18,000 to 26,000 iterations were 
used to establish. P-value threshold was set to between 0.995 and 1.0 for up-regulation, 0.47 and 1.0 
for down-regulation. Three categories were classified out of the12 GPs depending on network structures. 
Class 1: Thick and elongated neurons, but with a small amount of neurite branching. Class 1 could be 
distinguished from other classes in terms of loading the “Neurite_length” parameter on the top of the PN, 
such that “Neurite_length” controlled “Branch_point” and “Crossing_point”. The node located towards 
the bottom seems to suppress neurite growth. The neurite becomes a parent node, which dominates all 
the other parameters in the PN in order to facilitate its own growth. Namely, the branching points and 
intersections are increased in parallel with neurite elongation. The parameters of “EB_Area”, 
“EB_Perimeter” and “EB_FormFactor” are also related to “Neurite_length”, which perhaps suggests 
that neurites have differentiated normally from EBs and that the shape of NSs is not a circle (i.e., NS 
becomes flattened during differentiation). 
Class 2: Neurite elongation and branching are extensive. In this case, “Branch_point” is located  
on the top, suggesting that the “Branch_point” controls “Neurite_length” and “Crossing_point”. 
“Neurite_length” is expressed as the total length of all neurites per cell. “Branch_point” becomes the 
parent node in this PN because there are many random short neurites and the total length of all the 
branching short neurites at their branch points is regarded as the neurite length. Therefore, the promotion 
arrow from the branch point tends to be the parameter of neurites. Because there are so many random 
branch points, it is very likely that there are many short crossing intersections. Furthermore, since there 
are so many branches from the neurites which perhaps did not differentiate from EBs, the parameter of 
“Branch_point” might not be related to EB shape. Consequently, the EB shape tends to be round 
compared with that of Class 1 EBs. 
Class 3: larger NSs and less neurites. Different from classes 1 and 2, “Nuc_count” and “Nuc_area” 
are localized at the top in this PN. This suggests that cell proliferation in NSs is more predominant than 
neural cell outward migration. Common to these three classes, in case of that differentiated neural cell 
expanded outside of EB and neural differentiation related morphological parameters emerged above of 
PN. These parameters exert influence on the number of cells and the shape of the EB. Furthermore, 
when the differentiation is advanced, the PN tends to become complex. In fact, neural differentiation is 
not too advanced like as Class 3, it became the result of locating the parameter related to number of cells 
in the high rank from the parameter of the neuronal cell. The parameter concerning the EB is always Int. J. Mol. Sci. 2012, 13 203 
 
located in the subordinate position of the PN on any PN and this tendency corresponded to the theory 
that the shape changed depending on the number of cells and the progression of neuronal differentiation. 
3.9. Statistical Analysis 
All experiments in this study were performed in triplicate to test the reproducibility of the results. 
Statistical analysis was performed by two-tailed Student’s t-test. Relationships were considered 
statistically significant with p < 0.05. 
4. Conclusions 
Our study provides an advanced framework to integrate the gene expression and neuronal cell 
phenotypes for target prediction. Thus a combination of BNA and PCA clustering could provide 
compound-target prediction efficiency. We believe this method has considerable potential. For 
example, new markers could be implemented that enable predictive toxicology of active lead 
compounds. Combined with chemical structure knowledge and ligand-target prediction, such 
approaches could provide detailed mechanistic insight to help guide medicinal chemists early in the 
lead optimization process. Dealing with complexities of predictive toxicology will require 
breakthroughs in cellular image analysis, target prediction schemes and data mining. Our integration 
analysis of cellular phenotypes with gene expression represents a step forward in solving the DNT for 
environmental chemical assessment. 
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